Drug Database
Back to search

Poland· PL-100508147

Orebriton Plus

A medicinal product containing ticagrelorum + acidum acetylsalicylicum, registered in Poland by Zentiva, k.s..

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedOrebriton PlusATC—REGISTER NO.PL-100508147PACKS LISTED7CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ticagrelorum + acidum acetylsalicylicumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

URPL (Poland)
Active substance
Ticagrelorum + Acidum acetylsalicylicum
Manufacturer
Zentiva, k.s.
Country
Poland (PL)
ATC code
—
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 7

  • gtin
    05909991593315
  • gtin
    05909991593322
  • gtin
    05909991593339
  • gtin
    05909991593346
  • gtin
    05909991593353
  • gtin
    05909991593360
  • gtin
    05909991593377

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Ticagrelorum + acidum acetylsalicylicum in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ticagrelorum + acidum acetylsalicylicum products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Bulgaria · Клотинби
  • Czechia · Igzelym Duo, Orebriton Duo
  • Germany · Ticaass Apontis
  • Estonia · Igzelymas, Turcer
  • Spain · Ticagrelor/Ácido Acetilsalicílico Pharos
  • France · Orebrasa
  • Greece · Orebriton Duo
  • Croatia · Igzelym Duo, Orebriton Duo
  • Italy · Clotynbi, Turcer
  • Lithuania · Igzelymas, Turcer
  • Latvia · Igzelymas, Turcer
  • Malta · Ticagrelor/Acetylsalicylic Acid Pharos
  • Portugal · Clotynbi, Orebriton Duo
  • Romania · Orebriton Duo
  • Sweden · Cabritil, Pocira
  • Slovakia · Igzelym Duo, Orebriton Duo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ffc09abb-a0f8-4b15-9c3a-6f7b1ceb78ee
GET /v1/drugs/ffc09abb-a0f8-4b15-9c3a-6f7b1ceb78ee?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki twarde",
  "source": "urpl",
  "strength": "90 mg + 50 mg",
  "packaging": "05909991593315 ¦ Rp ¦ 165584\n56 kaps. w blistrze\n05909991593322 ¦ Rp ¦ 165585\n60 kaps.\n05909991593339 ¦ Rp ¦ 165586\n200 kaps. op. zbiorcze\n05909991593346 ¦ Rp ¦ 165587\n28 kaps.\n05909991593353 ¦ Rp ¦ 165588\n56 kaps. w blistrze perforowanym\n05909991593360 ¦ Rp ¦ 165589\n168 kaps. op. zbiorcze\n05909991593377 ¦ Rp ¦ 165590\n180 kaps.",
  "substance": "Ticagrelorum 90 mg + Acidum acetylsalicylicum 50 mg",
  "common_name": "Ticagrelorum + Acidum acetylsalicylicum",
  "pl_product_id": "100508147",
  "pozwolenie_nr": "29498",
  "auth_procedure": "DCP",
  "authorisation_validity": "2031-01-28"
}
API referenceMCP serverPlans

See everything about ticagrelorum + acidum acetylsalicylicum.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console